Combination Treatment With Ipragliflozin and Metformin: A Randomized, Double-Blind, Placebo-Controlled Study in Patients With Type 2 Diabetes Mellitus
Author:
Publisher
Elsevier BV
Subject
Pharmacology (medical),Pharmacology
Reference31 articles.
1. Renal Na+-glucose cotransporters;Wright;Am J Physiol Renal Physiol,2001
2. Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitus;Neumiller;Drugs,2010
3. The human kidney low affinity Na+/glucose cotransporter SGLT2: delineation of the major renal reabsorptive mechanism for D-glucose;Kanai;J Clin Invest,1994
4. Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes;Jabbour;Int J Clin Pract,2008
5. Treatment of patients with type 2 diabetes mellitus: new therapies on the horizon [in Dutch];Veltkamp;PW Wetenschappelijk Platform,2011
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. DEVELOPMENT OF OSMOTIC CONTROLLED RELEASE FORMULATION OF AN ANTIDIABETIC DRUG METFORMIN HYDROCHLORIDE;INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH;2020-12-01
2. Adverse Drug Events Observed with the Novel Sodium/Glucose Co-Transporter 2 Inhibitor Ipragliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Studies;Advances in Therapy;2020-08-26
3. Preparation and characterization of metformin hydrochloride controlled-release tablet using fatty acid coated granules;Drug Development and Industrial Pharmacy;2020-05-03
4. Efficacy and safety of ipragliflozin as add-on to metformin for type 2 diabetes: a meta-analysis of double-blind randomized controlled trials;Postgraduate Medicine;2019-09-05
5. Tolerability and Efficacy of Ipragliflozin in The Management of Inadequately Controlled Type 2 Diabetes mellitus: A Systematic Review and Meta-analysis;Experimental and Clinical Endocrinology & Diabetes;2018-06-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3